SCHEMBL7572691

SCHEMBL7572691

S=P(c1ccccc1-c1ccccc1)(C1CCCCC1)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
HTT P42858 1/20 0.33
HRH1 P35367 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
PTGS2 P35354 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1574869 0.79 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL3238343 0.69 MEN1 (0.42) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL22633981 0.68 PTGS2 (0.38) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL1256223 0.67 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2TDP1
SCHEMBL11510900 0.67 CYP2A6 (0.44) ALDH1A1TDP1PTGS2HPGDBCL2L1
SCHEMBL10778664 0.66 CYP3A4 (0.38) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL22634002 0.65 KIF11 (0.39) ALDH1A1PTGS2HSD17B10
SCHEMBL60703 0.64 PTGS2 (0.63) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL30407966 0.64 PTGS2 (0.63) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL28501418 0.64 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365776-B1 FROM ORGANOHALOGEN COMPOUND AND AMINE USING PALLADIUM COMPOUND CATALYST AND PROMOTER TAKASAGO INTERNATIONAL CORPORATION (JP) 2002-04-02 US disclosed
US-20020035295-A1 PROCESS FOR PRODUCING AROMATIC AMINES TAKASAGO INTERNATIONAL CORPORATION 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035295-A1 PROCESS FOR PRODUCING AROMATIC AMINES TYR, DDC, PNMT ALDH1A1 1669/4885MEN1 1606/4885KMT2A 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.